BAYRY - Bayer Aktiengesellschaft

Other OTC - Other OTC Delayed Price. Currency in USD
17.31
-0.53 (-3.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close17.84
Open17.36
Bid0.00 x 0
Ask0.00 x 0
Day's Range17.25 - 17.47
52 Week Range16.58 - 32.80
Volume2,357,876
Avg. Volume611,631
Market Cap65.032B
Beta (3Y Monthly)1.00
PE Ratio (TTM)9.38
EPS (TTM)1.84
Earnings DateN/A
Forward Dividend & Yield0.81 (4.24%)
Ex-Dividend Date2018-05-25
1y Target Est30.70
Trade prices are not sourced from all markets
  • Roundup Judge Loosens His Grip on Monsanto Ghosts Haunting Bayer
    Bloomberg18 hours ago

    Roundup Judge Loosens His Grip on Monsanto Ghosts Haunting Bayer

    U.S. District Judge Vince Chhabria has maintained a white-knuckle grip on the case, and has kept lawyers suing Bayer on an especially tight leash -- until now. In rulings before and during the first part of a trial in San Francisco federal court, the judge tossed witnesses and whittled evidence offered up by lawyers representing Ed Hardeman, one of more than 11,200 people in the U.S. suing Bayer over claims exposure to Roundup caused their cancer. When Hardeman’s lead lawyer strayed too far from his rules during her opening presentation, Chhabria sanctioned her and confiscated offending slides she had planned to show the jury.

  • Jury finding upends Bayer's Roundup defense strategy: experts
    Reuters22 hours ago

    Jury finding upends Bayer's Roundup defense strategy: experts

    Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said. Bayer shares tumbled more than 12 percent on Wednesday after a unanimous jury in San Francisco federal court found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma. The jury decision was a blow to Bayer after the judge in the Hardeman case, at the company's request, had split the trial, severely limiting evidence plaintiffs could present in the first phase.

  • The Wall Street Journalyesterday

    [$$] Bayer Shares Fall After Legal Setback on Roundup Weedkiller

    The verdict shows how the German company’s $63 billion acquisition of U.S. agriculture giant Monsanto Co.—which was designed to bolster Bayer’s fading fortunes—has now become its biggest potential liability. Bayer needs the tide to turn in its favor both to avoid what analysts fear could be billions in potential legal damages and to convince investors that its Monsanto bet was right. Bayer has said the extent of the litigation it now faces wasn’t foreseeable at the time of the Monsanto deal, which turned the inventor of aspirin into the world’s largest maker of seeds and pesticides.

  • Reutersyesterday

    Jury finding upends Bayer's Roundup defence strategy: experts

    Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said. Bayer shares tumbled more than 12 percent on Wednesday after a unanimous jury in San Francisco federal court found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma. The jury decision was a blow to Bayer after the judge in the Hardeman case, at the company's request, had split the trial, severely limiting evidence plaintiffs could present in the first phase.

  • Bloombergyesterday

    There's No Proof Roundup Causes Cancer But Questions Linger

    Regulators in the U.S., European Union and elsewhere have said it probably isn’t a carcinogen, and more than 800 studies back that up, including an epidemiological study undertaken by the National Cancer Institute that found glyphosate use wasn’t associated with overall cancer risk. Tina Levine, a former director of the Health Effects Division of the Office of Pesticide Programs in the U.S. Environmental Protection Agency, said human health concerns were minimal.

  • Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer
    Investor's Business Dailyyesterday

    Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer

    The market cap for Germany's Bayer shrank by more than $6 billion Wednesday after a jury said its Roundup weed killer caused cancer. Now, jurors must determine liability and damages.

  • Shares in Germany's Bayer plunge on US weed killer ruling
    Associated Pressyesterday

    Shares in Germany's Bayer plunge on US weed killer ruling

    BERLIN (AP) — Shares in chemicals manufacturer Bayer fell sharply Wednesday after a U.S. jury found the Roundup weed killer to have been a substantial factor in a California man's cancer.

  • Benzingayesterday

    Bayer's Legal Woes Mount As Jury Again Links Roundup To Cancer

    Roundup, a broad-spectrum, glyphosate-based herbicide, came into Bayer's fold with its June 2018 acquisition of U.S. agrochemical company Monsanto for $62.5 billion. Exposure to herbicides with glyphosate as an active ingredient increases the risk of cancer in those exposed by 41 percent, according to a research article published in ScienceDirect. The San Francisco jury's preliminary verdict comes after a California state court awarded $289 million in damages to a school groundskeeper in August 2018.

  • Bayer Stock Banged Up by Roundup Weedkiller Verdict
    InvestorPlaceyesterday

    Bayer Stock Banged Up by Roundup Weedkiller Verdict

    Wednesday was not kind to Bayer (OTCMKTS:BAYRY) stock as a jury found the company's Roundup weedkiller responsible for causing cancer.Source: Bayer A second U.S. jury -- a unanimous one in San Francisco federal court -- ruled on Tuesday was not related to the German company's liability for the cancer of Edwin Hardeman, the plaintiff. The liability and damages in the case will be decided by the same jury as part of a second trial phase set to begin on Wednesday.Bayer still denies that glyphosate or Roundup are at fault for causing cancer, adding that the business was disappointed with the jury making the decision it made. The business acquired Monsanto for $63 billion last year-the latter company has been making Roundup for a while now.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"We are confident the evidence in phase two will show that Monsanto's conduct has been appropriate and the company should not be liable for Mr. Hardeman's cancer," the company said. This is only the second of more than 11,000 Roundup lawsuits in the U.S., with the first one leading to a $78 million payout that is currently on appeal.Glyphosate is the most widely used weed killer in the world, with Roundup being the first such weed killer in the market. However, the product is no longer protected by a patent, so there are plenty of other iterations of the product available to the public. It is unclear how many sales of Roundup Bayer had in its most recent quarterly report. More From InvestorPlace * 5 Cloud Stocks to Help Your Portfolio Fly * 7 Small-Cap Stocks That Make the Grade * Top 7 Service Sector Stocks That Will Pay You to Own Them Compare Brokers The post Bayer Stock Banged Up by Roundup Weedkiller Verdict appeared first on InvestorPlace.

  • U.S. jury hears more evidence as second phase of Roundup cancer trial begins
    Reutersyesterday

    U.S. jury hears more evidence as second phase of Roundup cancer trial begins

    A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease. The jury in San Francisco federal court on Tuesday found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma, but did not find Bayer liable.

  • Barrons.comyesterday

    Bayer’s Latest Legal Setback Spooks Financial Markets

    Bayer‘s liabilities could grow after a West Coast jury finds that the German company’s weedkiller likely triggered cancer.

  • Reutersyesterday

    European stocks break 5-day rally; Bayer, BMW weigh on DAX

    European shares retreated from near six-month highs on Wednesday, with German stocks leading losses as chemicals producer Bayer and carmaker BMW tumbled, and as the European Union resisted British Prime Minister Theresa May's plea to delay Brexit. The pan-European STOXX 600 index fell 0.9 percent as investors booked profits after five sessions of gains, with Bayer's near 10 percent slump weighing the most.

  • Bayer's Blind Spot on Monsanto's Roundup May Cost Billions
    Bloombergyesterday

    Bayer's Blind Spot on Monsanto's Roundup May Cost Billions

    Bayer says science shows that the herbicide, which the German company gained in its $63 billion acquisition of Monsanto Co., is safe. Now that a second U.S. jury has linked the product to cancer, the uphill battle Chief Executive Officer Werner Baumann is fighting just got steeper. Roundup became the company’s leading headache after the June 7 completion of the Monsanto deal that Baumann entered to remain a global competitor in seeds and agricultural products.

  • Reutersyesterday

    Bayer shares slide after latest Roundup cancer ruling

    Shares in Germany's Bayer's fell more than 12 percent on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer. Tuesday's unanimous jury decision in San Francisco federal court was not a finding of Bayer's liability for the cancer of plaintiff Edwin Hardeman. Bayer, which denies allegations that glyphosate or Roundup cause cancer, said it was disappointed with the jury's initial decision.

  • Market Exclusive2 days ago

    Market Morning: Fed Speaks, FedEx Falls, Starbucks Stars, Bayer In Trouble

    Fed Speaks Today on Balance Sheet, Rate Hike Projections There are no expectations for the Fed to raise interest rates at the post FOMC meeting press conference today at 2:00pm, but traders will be looking for indications on when the balance sheet reduction program will end and how many rate hikes the Federal Reserve expects […]The post Market Morning: Fed Speaks, FedEx Falls, Starbucks Stars, Bayer In Trouble appeared first on Market Exclusive.

  • The Wall Street Journal2 days ago

    [$$] Bayer Tumbles After Fresh Roundup Ruling

    AG (BAYN.XE) fell sharply lower early on Wednesday after a San Francisco jury late on Tuesday found that the use of Monsanto-branded glyphosate-based weedkillers was a substantial factor in a man developing cancer. Jurors will now hear evidence in a second phase of the trial to determine whether Monsanto--which the German company acquired last year--should be held liable, which could entail substantial financial penalties for Bayer. At 0846 GMT, Bayer shares were trading 11.7% lower at EUR61.55.

  • The Wall Street Journal2 days ago

    [$$] Jury Finds Bayer's Roundup Weedkiller Caused Man's Cancer

    The six-person jury in U.S. District Court in San Francisco now is set to begin hearing evidence to separately weigh whether Bayer’s Monsanto unit should be held liable, a decision that could bring substantial financial damages against the company. The verdict issued Tuesday marks another setback for Bayer, which has come under intense pressure since a jury in August reached a $289.2 million verdict in the first case over the weedkiller to go to trial. Bayer has appealed that verdict, which the trial judge cut down to $78.5 million.

  • Reuters2 days ago

    Second U.S. jury finds Bayer's Roundup caused cancer

    A U.S. jury on Tuesday found Bayer AG's glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case. Tuesday's unanimous jury decision in San Francisco federal court, which came after five days of deliberation, was not a finding of Bayer's liability for the cancer of plaintiff Edwin Hardeman.

  • TheStreet.com2 days ago

    Bayer's Roundup Herbicide Caused Man's Cancer, California Jury Finds: Report

    A federal court jury found that Bayer's Roundup herbicide was a factor in causing a California man's cancer, setting the stage for a second phase to determine liability and damages, according to a published report.

  • Reuters2 days ago

    U.S. jury rules against Bayer in Roundup cancer case

    A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages. The jury in San Francisco federal court found Roundup, one of the world's most widely-used weed killers, to be responsible for the cancer of California resident Edwin Hardeman.

  • Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead?
    Zacks2 days ago

    Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead?

    Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead?